BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19852957)

  • 1. Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjögren's syndrome-like exocrinopathy.
    Schenke-Layland K; Xie J; Magnusson M; Angelis E; Li X; Wu K; Reinhardt DP; Maclellan WR; Hamm-Alvarez SF
    Exp Eye Res; 2010 Feb; 90(2):223-37. PubMed ID: 19852957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjögren's syndrome.
    Schenke-Layland K; Xie J; Angelis E; Starcher B; Wu K; Riemann I; MacLellan WR; Hamm-Alvarez SF
    Matrix Biol; 2008 Jan; 27(1):53-66. PubMed ID: 17689946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland.
    Wu K; Joffre C; Li X; MacVeigh-Aloni M; Hom M; Hwang J; Ding C; Gregoire S; Bretillon L; Zhong JF; Hamm-Alvarez SF
    Exp Eye Res; 2009 Sep; 89(3):319-32. PubMed ID: 19345210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of cathepsins and obesity-induced proinflammatory cytokines in lacrimal glands of male NOD mouse.
    Li X; Wu K; Edman M; Schenke-Layland K; MacVeigh-Aloni M; Janga SR; Schulz B; Hamm-Alvarez SF
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5019-29. PubMed ID: 20463324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant proteolytic digestion of biglycan and decorin by saliva and exocrine gland lysates from the NOD mouse model for autoimmune exocrinopathy.
    Yamachika S; Brayer J; Oxford GE; Peck AB; Humphreys-Beher MG
    Clin Exp Rheumatol; 2000; 18(2):233-40. PubMed ID: 10812497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome.
    Yamachika S; Nanni JM; Nguyen KH; Garces L; Lowry JM; Robinson CP; Brayer J; Oxford GE; da Silveira A; Kerr M; Peck AB; Humphreys-Beher MG
    J Rheumatol; 1998 Dec; 25(12):2371-80. PubMed ID: 9858432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development.
    da Costa SR; Wu K; Veigh MM; Pidgeon M; Ding C; Schechter JE; Hamm-Alvarez SF
    Exp Eye Res; 2006 Jan; 82(1):33-45. PubMed ID: 16005870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Matrix Metalloproteinases 2 and 9 in Lacrimal Gland Disease in Animal Models of Sjögren's Syndrome.
    Aluri HS; Kublin CL; Thotakura S; Armaos H; Samizadeh M; Hawley D; Thomas WM; Leavis P; Makarenkova HP; Zoukhri D
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5218-28. PubMed ID: 26244298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
    Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
    Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.
    Cha S; Brayer J; Gao J; Brown V; Killedar S; Yasunari U; Peck AB
    Scand J Immunol; 2004 Dec; 60(6):552-65. PubMed ID: 15584966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rab27a Contributes to Cathepsin S Secretion in Lacrimal Gland Acinar Cells.
    Fu R; Edman MC; Hamm-Alvarez SF
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The miRNA Landscape of Lacrimal Glands in a Murine Model of Autoimmune Dacryoadenitis.
    Singh Kakan S; Li X; Edman MC; Okamoto CT; Hjelm BE; Hamm-Alvarez SF
    Invest Ophthalmol Vis Sci; 2023 Apr; 64(4):1. PubMed ID: 37010857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis.
    Ju Y; Janga SR; Klinngam W; MacKay JA; Hawley D; Zoukhri D; Edman MC; Hamm-Alvarez SF
    Exp Eye Res; 2018 Nov; 176():243-251. PubMed ID: 30201519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjögren's syndrome (SJS)-like disease of the C57BL/6.NOD-Aec1Aec2 mouse.
    Nguyen CQ; Sharma A; She JX; McIndoe RA; Peck AB
    Exp Eye Res; 2009 Mar; 88(3):398-409. PubMed ID: 19103199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome.
    Tsubota K; Fujita H; Tadano K; Takeuchi T; Murakami T; Saito I; Hayashi Y
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
    Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
    PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice.
    Kong L; Robinson CP; Peck AB; Vela-Roch N; Sakata KM; Dang H; Talal N; Humphreys-Beher MG
    Clin Exp Rheumatol; 1998; 16(6):675-81. PubMed ID: 9844759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacrimal Gland Inflammation Deregulates Extracellular Matrix Remodeling and Alters Molecular Signature of Epithelial Stem/Progenitor Cells.
    Umazume T; Thomas WM; Campbell S; Aluri H; Thotakura S; Zoukhri D; Makarenkova HP
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8392-402. PubMed ID: 26747770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.
    Shah M; Edman MC; Janga SR; Shi P; Dhandhukia J; Liu S; Louie SG; Rodgers K; Mackay JA; Hamm-Alvarez SF
    J Control Release; 2013 Nov; 171(3):269-79. PubMed ID: 23892265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
    Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
    Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.